Why the study?
Methodological approaches, analyses, and interpretations of heart rate variability vary extensively, with ongoing debates on reliability and utility amplified by wearable devices.
This guideline provides evidence-based recommendations for the rigorous measurement, analysis, and interpretation of heart rate variability in human cardiovascular research.
Clinicians should limit HRV to risk stratification only; challenges its validity as a sympathovagal balance or sympathetic marker in research.
Heart rate variability (HRV) is a widely utilized approach for investigating cardiovascular health and human performance. Methodological approaches, analyses, and interpretations of HRV can vary extensively, and scientific debates on HRV reliability and utility remain. These debates have been amplified in recent years by the rapid growth and ubiquity of wearable devices, and their incorporation into scientific research studies. The present guidelines paper takes an evidence-based approach to propose more consistent and rigorous measurement and interpretation of HRV within human cardiovascular research and application. First, HRV has some utility as a cardiovascular risk stratification tool, but is not appropriate to employ as a specific marker of cardiac sympathetic outflow or sympathovagal balance. While time-domain and spectral analysis can more accurately reflect respiratory modulation of cardiac vagal (parasympathetic) activity, caution is necessary to avoid overinterpretation, particularly with respect to the concept of "vagal tone". Numerous experimental, demographic, and environmental factors influence HRV assessment, interpretation, and reliability. Specifically, it is critical to account for non-modifiable (age, sex, race/ethnicity, etc.) and modifiable (i.e., exercise, physical fitness, etc.) factors within participant samples. Furthermore, technical approaches such as the HRV input signal (e.g., electrocardiography vs. photoplethysmography), length of recording, location of recordings (i.e., laboratory vs. field), respiratory rate and depth, and analytical approaches (i.e., time vs. frequency domain) can all impact rigor, reliability, and study interpretations. Finally, with respect to the rapid advancements of HRV assessment using wearable technology, investigators should interpret and contextualize findings within the limitations outlined in this guideline review.
No takes yet. Share an insight, caveat, or question.
Carter et al. (2026) conducted a review in Cardiovascular health and human performance. Heart rate variability (HRV) assessment was evaluated. Heart rate variability has utility as a cardiovascular risk stratification tool but is not appropriate to employ as a specific marker of cardiac sympathetic outflow or sympathovagal balance.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: